Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DX Bako

DX Bako?uq=kzBhZRuG
2007 FOUNDED
PRIVATE STATUS
101-200 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of specialty laboratory testing services. The company offers a comprehensive testing menu including complete anatomic pathology services, proprietary molecular genetic testing, and peripheral neuropathy immuno-histochemical testing services. It also offers an integrated portfolio of office-dispensed therapeutics.

Website
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Laboratory Services (Healthcare)
Primary Office
  • 6240 Shiloh Road
  • Alpharetta, GA 30005
  • United States

+1 (855) 000-0000

DX Bako Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore DX Bako‘s full profile, request access.

Request full access to PitchBook

DX Bako Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore DX Bako‘s full profile, request access.

Request full access to PitchBook

DX Bako Executive Team (9)

Name Title Board
Seat
Contact
Info
Dan Spragle President & Chief Operating Officer
Scott Bakotic Chief Financial Officer
Nina Hobin Chief Compliance Officer
David Jenkins Chief Information Officer
John Garrigan Chief Commercial Officer & Head of Sales

1 Former Executive

You’re viewing 5 of 9 executives. Get the full list »